Priming of hematopoietic progenitor cells by plerixafor and filgrastim in children with previous failure of mobilization with chemotherapy and/or cytokine treatment

Journal of Pediatric Hematology/Oncology

Volumn 34, Issue 2, 2012, Pages 146-150

  Sevilla, Julián ^a   Schiavello, Elisabetta ^b   Madero, Luis ^c   Pardeo, Manuela ^d   Guggiari, Elena ^e   Baragaño, Marta ^e   Luksch, Roberto ^b   Massimino, Maura ^b  

^a HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c HOSPITAL QUIRÓN   (Spain)

^d BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

CD34; drugs; hematopoietic stem cells; leukapheresis; plerixafor; stem cell mobilization

Indexed keywords

CARBOPLATIN; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLERIXAFOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; VINCRISTINE;

ADOLESCENT; ADULT; ANXIETY DISORDER; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BLOOD VOLUME; BONE PAIN; CANCER RADIOTHERAPY; CELL COUNT; CHILD; CLINICAL ARTICLE; COMPASSIONATE USE; DRUG FEVER; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EWING SARCOMA; FEMALE; HODGKIN DISEASE; HUMAN; LARGE CELL LYMPHOMA; LEUKAPHERESIS; MALE; MEDULLOBLASTOMA; MULTIPLE CYCLE TREATMENT; NIGHTMARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STEM CELL MOBILIZATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; CHILD; COMPASSIONATE USE TRIALS; CYTOKINES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HETEROCYCLIC COMPOUNDS; HUMANS; MALE; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES;

EID: 84857924680     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31821c2cb8     Document Type: Article

References (17)

1. Flomenberg N, Devine SM, Dipersio JF, et al. The use of AMD3100 plus filgrastim for autologous hematopoietic progenitor cell mobilization is superior to filgrastim alone. Blood. 2005;106:1867-1874.
2. DiPersio JF, Micallef IN, Stiff PJ, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. J Clin Oncol. 2009;27:4767-4773.
3. DiPersio JF, Stadtmauer EA, Nademanee A, et al. Plerixafor and filgrastim versus placebo and filgrastim to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood. 2009;113:5720-5726.
4. Flomenberg N, DiPersio J, Calandra G. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells. Acta Haematol. 2005;114:198-205.
5. Toledano H, Yahel A, Cohen IJ, et al. Successful mobilisation, harvest and transplant of peripheral blood stem cells using AMD 3100 and filgrastim following high dose craniospinal irradiation for medulloblastoma in a young child. Pediatr Blood Cancer. 2010;54:613-615.
6. Aabideen K, Anoop P, Ethell ME, et al. The feasibility of plerixafor as a second-line stem cell mobilizing agent in children. J Pediatr Hematol Oncol. 2011;33:65-67.
7. Kawano Y, Takaue Y, Watanabe T, et al. Efficacy of the mobilization of peripheral blood stem cells by granulocyte colony-stimulating factor in pediatric donors. Cancer Res. 1999;59:3321-3324.
8. de la Rubia J, Díaz MA, Verdeguer A, et al. Donor-age related differences in peripheral blood progenitor cell mobilization with rHu-filgrastim. Transfusion. 2001;41:201-205.
9. Sevilla J, González-Vicent M, Madero L, et al. Large volume leukapheresis in small children: Safety profile and variables affecting peripheral blood progenitor cell collection. Bone Marrow Transplant. 2003;31:263-267.
10. Pulsipher MA, Levine JE, Hayashi RJ, et al. Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The pediatric blood and marrow transplant consortium experience (PBMTC) 1996-2003. Bone Marrow Transplant. 2005;35:361-367.
11. Alejandra Bernardo V, Szechung Ng J, Joyce MJ. Use of Plerixafor with Granulocyte Colony-Stimulating Factor for Stem Cell Mobilization in a Pediatric Patient. Ann Pharmacother. 2011 [Epub ahead of print] PMID: 21285407.
12. Flatt T, Lewing K, Gonzalez C, et al. Successful mobilization with AMD3100 and filgrastim with engraftment of autologous peripheral blood stem cells in a heavily pretreated pediatric patient with recurrent Burkitt lymphoma. Pediatr Hematol Oncol. 2010;27:138-149.
13. Robertson KA, Pradhan K, Goebel S, et al. Mobilization of peripheral blood CD34 stem cells in a heavily pre-treated pediatric medulloblastoma patients using AMD3100 and filgrastim. Biol Blood Marrow Transplant. 2006;12:S75-S76.
14. Stephen K, Montgomery K, Bateman C, et al. Successful mobilisation, harvest, and transplant of stem cells following AMD3100 in 3 pediatric patients? The Australian experience. Biol Blood Marrow Transplant. 2006;12:S157.
15. Fesler MJ, Kudva G, Petruska PJ. Plerixafor and pegylated filgrastim: A case of safe and effective hematopoietic stem cell mobilization. Bone Marrow Transplant. 2010;45:1367-1368.
16. Sevilla J, Gonzalez-Vicent M, Madero L, et al. Granulocyte colony stimulating factor alone at 12 microg/kg twice a day for 4 days for peripheral blood progenitor cell priming in pediatric patients. Bone Marrow Transplant. 2002;30:417-420.
17. Nimmagadda S, Sweiss K, Mahmud N, et al. Plerixafor given before the third leukapheresis to rescue an unsuccessful stem cell mobilization with CY and filgrastim. Bone Marrow Transplant. 2010;45:1121-1122.